WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Ramani Varanasi, MS, MBA has joined the company as Vice President of Business Development. The Company also announced that Stephen DiPalma, MBA has been promoted from Chief Financial Officer to Executive Vice President of Business Operations and Chief Financial Officer and that Joanne Kamens, Ph.D., formerly Director of Discovery Research, has been named Senior Director.
